Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. I.C. (Isabelle) van Gelder

Publicaties

Association between atherosclerosis and atrial fibrillation progression in patients with paroxysmal atrial fibrillation: Data from the RACE V study

Atrial fibrillation screening: time for precision, not just detection

Clinical practice guideline implementation: challenges and solutions for improved cardiovascular care: A Report from the European Society of Cardiology Cardiovascular RoundTable

Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease

Heart rate in early rhythm control therapy in patients with atrial fibrillation

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis

Risk prediction of atrial fibrillation progression in patients with paroxysmal atrial fibrillation: data from the RACE V study

Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study

Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Pers/media

Remote ECG Screening Ups Atrial Fibrillation Detection ‘Modestly’

Hart op hol, geen paniek.

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 8 – Fatsoenlijk werk en economische groeiSDG 9 – Industrie, innovatie en infrastructuurSDG 13 – Klimaatactie

Meer informatie over de Sustainable Development Goals.